
Print Smarter, Not Harder: WithMe, Inc. Rolls Out PrintWithMe Office Solution for Multifamily and Commercial Workplaces
CHICAGO--(BUSINESS WIRE)-- WithMe, Inc., a leader in technology-enabled printer solutions and coffee amenities, is expanding its portfolio with the introduction of the PrintWithMe Office Solution, a modern, multi-functional printer designed to support on-site teams across multifamily communities and commercial workplaces.
'Workplace printing has been an operational pain point for the people who keep things running day in and day out,' said Jeff Lail, COO of WithMe. 'They deserve simple, reliable tools that eliminate the friction that's defined office printing for too long."
Developed to meet the needs of leasing teams and office staff, the PrintWithMe Office Solution addresses a growing demand among small and mid-sized businesses to modernize outdated print infrastructure. Whether in a multifamily community, coworking space or office network, teams face the same recurring challenges: large-footprint devices with long-term contracts, inventory management and service hassles that require significant IT involvement, and unclear costs. WithMe's solution offers a simpler approach.
Unlike traditional managed print contracts, the PrintWithMe Office Solution offers clear, flexible terms with no long-term commitments. The setup is fully remote and requires minimal involvement from on-site IT teams. The printer's compact footprint makes it ideal for offices with limited space, and its proven 99%+ uptime, paired with seven-day-a-week live customer support, ensures uninterrupted service.
'Workplace printing has long been an operational pain point for the people who keep things running day in and day out,' said Jeff Lail, COO of WithMe. 'They deserve simple, reliable tools that eliminate the friction that's defined office printing for far too long. The PrintWithMe Office Solution was built to do exactly that — streamlining workflows, containing costs, and giving teams the freedom to focus on what truly matters.'
PrintWithMe Office Solution pairs compact, wireless hardware with cloud-managed software and predictable pricing. Each printer includes a set number of pages per month, copying and scanning capabilities, and automated paper and toner shipments. Optional upgrades allow properties and businesses to expand their plan with additional pages.
WithMe's amenities for multifamily residents — PrintWithMe and SipWithMe — are trusted by 84% of the NMHC Top 50 Managers. The PrintWithMe Office Solution builds on that legacy to serve a broader universe of workplace teams looking for simpler, smarter printing options.
To learn more about the PrintWithMe Office Solution and other WithMe amenities, visit the company's website.
About WithMe, Inc.
WithMe, Inc. makes lives better every day through convenient, technology-enabled amenities for the multifamily industry and beyond. WithMe's PrintWithMe and SipWithMe solutions simplify resident printing and coffee, enabling property management teams to provide a superior living experience while reducing costs, optimizing spend and improving operational efficiency.
PrintWithMe powers printer amenities and office solutions at thousands of multifamily, cafe and coworking locations across all 50 states. SipWithMe is redefining multifamily coffee by pairing reliable, high-performance machines with fresh, craft-roasted coffee.
WithMe is an Inc. 5000 fastest-growing company, appearing on the list for the past four consecutive years, as well as a two-time NAA Top Employer.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
Premium brand pet food plant opens in Rockingham County
ROCKINGHAM COUNTY, N.C. (WGHP) — A premium brand pet food plant is coming to the Triad all the way from Italy. Farmina Pet Foods will be opening its first-ever U.S. manufacturing plant in Rockingham County. It's a major investment for the region. FPF's owner and CEO, Dr. Angelo Russo, said that it was North Carolina's hospitality, good conditions for economic growth and an abundance of qualified workers that stood out to them. For Rockingham County, it will bring up to 300 more jobs and technologies from around the world. North Carolina Senator Phil Berger said now is a fascinating time for the pet industry. 'Fewer people are having kids, but … more getting dogs … and cats. I don't want to forget about our feline friends, but it's something people care a great deal about,' Berger said. Berger described FPF as one of the most reputable pet food brands that will bring a lot of growth to the local economy. 'Good, high-paying manufacturing jobs. Great for Rockingham County,' he said. In Reidsville, FPF will be opening its first U.S. manufacturing facility, and they have ambitious plans to deliver the best quality pet foods. FPF's North America CEO, Loris Rinaldi, said it was a $115 million investment. He is confident that it will be worth it for both the company and the county. 'This facility is designed to expand and have three times the production capacity we have today, and that additional investment is for the 300 people that will run this facility 24/7,' Rinaldi said. The facility will run with some cutting-edge technology. 'All of our bags are packed with nitrogen, which keeps everything fresh until you open the bag,' Rinaldi said. After having facilities in Italy and South America, this would be FPF's fifth facility, and they could not have found a better place to start off their North American venture. 'Your kind welcome … Economically speaking, the good conditions you give to us and a lot of qualified workers,' Russo said. Russo said this is just the beginning of the journey. According to Rinaldi, they will import machines from Japan, Italy and France for their technology. FPF's production will begin in July. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
17 minutes ago
- Yahoo
Avidity Biosciences, Inc. (RNA) Initiated with a Strong Buy at Raymond James
Avidity Biosciences, Inc. (NASDAQ:RNA) is one of the 13 Biotech Stocks with Huge Upside Potential. Raymond James has started coverage of Avidity Biosciences, Inc. (NASDAQ:RNA), with a Strong Buy rating and a price objective of $65. A scientist holding a vial of a promising product candidate for therapeutic development. The rating is part of a larger biotech sector note, in which the firm sees favorable risk/reward across the board. Raymond James points out that less de-risked platforms can produce the most outsized returns, even if companies with de-risked, high probability-of-success assets are frequently viewed with greater certainty. The firm stresses its confidence in del-zota, which is anticipated to be the first medicine from Avidity Biosciences, Inc. (NASDAQ:RNA)'s antibody oligonucleotide conjugate (AOC) platform to be approved. Avidity Biosciences, Inc. (NASDAQ:RNA) is becoming more well-known for its AOC platform, which targets muscle disorders by combining oligonucleotides and antibodies. According to Raymond James, one of the platform's top candidates, Del-Zota, has a strong chance of being approved. The $65 objective is in line with the firm's opinion that early-stage, less-risked assets can yield higher returns and points out faith in the platform's revolutionary potential. Avidity Biosciences, Inc. (NASDAQ:RNA) is a biopharmaceutical firm dedicated to developing a novel type of RNA treatment known as Antibody Oligonucleotide Conjugates, or AOCs. While we acknowledge the potential of RNA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025. Disclosure. None.
Yahoo
19 minutes ago
- Yahoo
Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer, announced today that members of its senior management team will present and participate in the Goldman Sachs 46th Annual Global Healthcare Conference on Wednesday, June 11th at 10:00 am ET. A live webcast of the presentation can be accessed through the Investors section of the Company's website at Following the live presentation, a replay of the webcast will be available on the Company's website following the presentation date. About Lyell Immunopharma, Inc. Lyell is a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with hematologic malignancies and solid tumors. To realize the potential of cell therapy for cancer, Lyell utilizes a suite of technologies to endow CAR T cells with attributes needed to drive durable tumor cytotoxicity and achieve consistent and long-lasting clinical responses, including the ability to resist exhaustion, maintain qualities of durable stemness and function in the hostile tumor microenvironment. To learn more, please visit Contact: Ellen RoseSenior Vice President, Communications and Investor Relationserose@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data